Common Mutations in Greek HNPCC Patients
Author Information
Author(s): Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis N J, Triantafillidis J K, Fountzilas G, Kosmidis P A, Razis E, Georgoulias V A, Nasioulas G
Primary Institution: Molecular Biology Research Center HYGEIA
Hypothesis
What are the mutations in the hMLH1 and hMSH2 genes in Greek families with hereditary nonpolyposis colorectal cancer (HNPCC)?
Conclusion
The study identified pathogenic mutations in 78% of the families analyzed, with a significant number of novel mutations found in the hMSH2 gene.
Supporting Evidence
- Seven out of nine families analyzed had pathogenic mutations.
- Four of the mutations identified were novel.
- The majority of mutations were found in the hMSH2 gene.
Takeaway
This study looked at families in Greece who might have a genetic risk for certain cancers and found many had mutations that could cause these cancers.
Methodology
The study involved genetic testing of 64 individuals from 28 families, focusing on mutations in the hMLH1 and hMSH2 genes using various molecular biology techniques.
Potential Biases
Potential bias in family history reporting could misguide the assignment of families into risk categories.
Limitations
The sample size is relatively small, and the accuracy of family history may not always be reliable.
Participant Demographics
Participants were from nine Greek families with a history of colorectal cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website